✨ Health and Communications Notices
NEW ZEALAND GAZETTE, No. 41 — 23 APRIL 2015
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Mabthera
Rituximab 10mg/mL
Concentrate for infusion
Roche Products (NZ) Limited
F Hoffmann-La Roche Limited, Basel, Switzerland
Genentech Inc, California, United States of America
Roche Diagnostics GmbH, Mannheim, Germany
Genentech Inc, Oregon, United States of America
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Ristova
Rituximab 10mg/mL
Concentrate for infusion
Roche Products (NZ) Limited
F Hoffmann-La Roche Limited, Basel, Switzerland
Genentech Inc, California, United States of America
Roche Diagnostics GmbH, Mannheim, Germany
Genentech Inc, Oregon, United States of America
Dated this 16th day of April 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go2335
Radiocommunications Regulations (General User Radio Licence for Satellite Services) Notice 2015
Pursuant to Regulation 9 of the Radiocommunications Regulations 2001 ("the Regulations") made under section 116(1)(b) of the Radiocommunications Act 1989, and acting under delegated authority from the chief executive, I give the following notice.
Notice
-
Short title and commencement—
(1) This notice is the Radiocommunications Regulations (General User Radio Licence for Satellite Services) Notice 2015.
(2) This notice comes into force on 21 April 2015. -
Licence—
(1) Licence Name: General User Radio Licence for Satellite Services.
(2) Licence: Any person may transmit radio waves using Satellite ground stations for the purpose of Mobile Satellite Services (MSS), Satellite News Gathering (SNG) services, and Very Small Aperture Terminal (VSAT) satellite services: being handheld, portable, transportable (vehicle mounted and re-locatable) and fixed radio transmitters, in accordance with the applicable terms, conditions and restrictions of this notice.
(3) Licence number: 248474
(4) Commencement date: 21 April 2015. -
Spectrum—
Low (MHz) High (MHz) Reference Frequency (MHz) Maximum Power dBW e.i.r.p. Remarks 399.9 400.5 400.2 -3.0 Special condition 1 1610 1660.5 1635.25 10 Special condition 1 14000 14500 14250 56 Special conditions 1 and 6 14000 14500 14250 67 Special conditions 2, 4, and 6 14000 14500 14250 62 Special conditions 3, 5, and 6 -
Location—
(1) Transmit Location: All New Zealand.
(2) Receive Location: All New Zealand. -
Special conditions—
Next Page →
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare16 April 2015
Medicines Act 1981, Distribution of New Medicines, Mabthera, Rituximab, Ristova
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
🚂 Radiocommunications Regulations (General User Radio Licence for Satellite Services) Notice 2015
🚂 Transport & CommunicationsRadiocommunications Regulations, General User Radio Licence, Satellite Services, Mobile Satellite Services, VSAT
NZ Gazette 2015, No 41